Soluble receptor-induced retroviral infection of receptor-deficient cells
about
Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infectionPhosphatidylserine treatment relieves the block to retrovirus infection of cells expressing glycosylated virus receptors.The soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cellsReceptor Binding and Low pH Coactivate Oncogenic Retrovirus Envelope-Mediated FusionCritical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediateInsulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stabilityIdentification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.Role of calcium in protein folding and function of Tva, the receptor of subgroup A avian sarcoma and leukosis virusA study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DSoluble receptor potentiates receptor-independent infection by murine coronavirus.Receptor-induced conformational changes of murine coronavirus spike protein.Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEMReceptor-independent infection of murine coronavirus: analysis by spinoculationSimple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoproteinMolecular gymnastics at the herpesvirus surface.Hepatitis C virus is primed by CD81 protein for low pH-dependent fusionPremature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machineryThe mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infectionThe soluble amino-terminal region of HVEM mediates efficient herpes simplex virus type 1 infection of gD receptor-negative cells.Expression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2.Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.Retroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry.The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity.Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.Evidence that the transmembrane domain proximal region of the human T-cell leukemia virus type 1 fusion glycoprotein gp21 has distinct roles in the prefusion and fusion-activated states.
P2860
Q24529140-7EAB3347-FAF6-43E5-AA33-8679E12E3CF3Q24812508-A1894A52-2DB0-47E0-B960-CACC2C4CE5B1Q27302868-99E69EF2-45F5-427A-9B1C-CDA9029B7E0FQ27490307-678BB3A6-A992-46F8-9955-BC85129923D8Q30306131-579FDFDD-02ED-4CD0-BAED-13320B056A8DQ30448472-32E0D6B5-6A93-4A70-8E85-1D44214AEABCQ30448708-8A0D70ED-46C2-4857-A56D-CC64615A79D8Q33622464-D4AF9E1D-B81E-4594-8B64-546EA2112296Q33835427-EDD14F5D-465B-4972-9C9F-0ABE2266AD3AQ33850422-D6192348-F1E2-448D-B652-EB0EEC43C309Q34187711-3651249C-B96B-4752-AB7C-447F47E707F9Q34233037-C5F08B32-8AD1-4117-AC5B-B8AFBAD38CCAQ34329104-1229B444-2BBE-47B0-A373-BF9C954196F7Q34360420-9DCFB9D9-F825-4C53-A5A3-25D0DFBF93D5Q34546016-29445B5B-520D-4423-9DEF-DCA53CE84903Q34647808-14F74858-8E55-471F-8307-CFB33E3C77DDQ34979037-5B2D6AEA-2B3C-4A54-8413-2208C19D850CQ35102490-94E1013D-38AA-4031-A83C-66B5DE3DBCEFQ35182834-F8388EDC-17EB-451E-B78F-C8C2639B1D4EQ35515383-B75E1BEE-B657-4E46-9F58-0C004A699416Q35543037-65307079-B7B5-426C-9F59-9FC8227803EAQ35774736-73850B73-ABE2-47B5-9352-D37F7B43FE2AQ37746382-4B3BA540-6106-43EA-9A5F-5A6E94F53517Q39683497-5BF9EF9F-FEB9-47D4-A5D7-C4F4045FB2B0Q39686823-00FB51A5-740B-49F6-A937-17ABAAC3370CQ40008992-73FB7DE7-AB47-4627-BB18-1A694536EA00Q40162632-05AE4574-7A0F-4255-AD13-32EC88DF82CCQ40304966-28705C0A-F300-42F9-8D8D-9153FA10E063Q40579178-2330859D-4F71-408A-A6C3-57CD5EF2C06FQ43763067-14BF03C8-789F-4C6E-8CAC-5BFE2A5AAEAA
P2860
Soluble receptor-induced retroviral infection of receptor-deficient cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Soluble receptor-induced retroviral infection of receptor-deficient cells
@ast
Soluble receptor-induced retroviral infection of receptor-deficient cells
@en
type
label
Soluble receptor-induced retroviral infection of receptor-deficient cells
@ast
Soluble receptor-induced retroviral infection of receptor-deficient cells
@en
prefLabel
Soluble receptor-induced retroviral infection of receptor-deficient cells
@ast
Soluble receptor-induced retroviral infection of receptor-deficient cells
@en
P2860
P1433
P1476
Soluble receptor-induced retroviral infection of receptor-deficient cells
@en
P2093
P2860
P304
P356
10.1128/JVI.74.14.6469-6475.2000
P577
2000-07-01T00:00:00Z